The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients ...

As an alternative, some doctors have been prescribing metformin—an oral diabetes drug—off-label for weight loss ... says ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

SOL-1 expected to be fully randomized by YE 2024 with topline data expected in Q4 2025 Active clinical trial sites now ...

Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

POTOMAC, MD / ACCESSWIRE / November 14 ... including sales of over-the-counter products, white, and private label services.

Catheter Precision, Inc. , a U.S.-based innovative medical device company focused on electrophysiology products, today announced it has received its first purchase order for LockeT from the New York ...

You're never too young to start eating for your heart. Science suggests these foods could help prevent clogged arteries. The ...

At the 42nd Annual Chemotherapy Foundation Symposium, Erin Mulvey, MD, discussed the significant progress being made in the ...

Akebia Therapeutics®, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the American Journal of Kidney Disease has ...

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...